• SQI Diagnostics Updates Clinical Progress on Novel COVID-19 Tests americanpharmaceuticalreview
    October 30, 2020
    SQI Diagnostics updated the Company's clinical development progress for its three novel Covid-19 tests, highlighted by confirmation from the U.S. Food and Drug Administration (FDA) that Emergency Use Authorization (EUA) submission is acceptable for ...
  • SQI Diagnostics to Announce Second Quarter 2018 Results biospace
    April 28, 2018
     SQI Diagnostics In today announced that it plans to release its financial and operational results for the three and six months ended March 31, 2018 at 5:00 p.m.
PharmaSources Customer Service